American Shared Hospital Services (NYSE American: AMS), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services, announced today that it will hold a conference call to discuss its first quarter 2026 financial results on May 14 at 12:00 p.m. ET. The company's financial results press release will be issued before the market opens on the same day.
The call is significant for investors and industry observers as it will provide a detailed look at the company's performance in its two primary segments: equipment leasing and direct patient care services. American Shared Hospital Services has been expanding its footprint in the cancer treatment market, particularly through its Gamma Knife, proton therapy, and advanced radiation therapy services, which are critical for treating complex cancers with precision.
Participants can access the call by dialing 1-844-413-3972 (domestic) or 1-412-317-5776 (international) at least 10 minutes prior to the start time. A simultaneous webcast will be available through the company's website at www.ashs.com or directly via this link. A replay will be available from May 14 through May 21 by calling 1-855-669-9658 or 1-412-317-0088, using access code 6753554. The replay will also be archived on the company's website.
American Shared Hospital Services provides turnkey solutions to cancer treatment centers, health systems, and cancer networks across North and South America. The company collaborates with partners to develop and expand cancer service lines, offering integrated care in local community settings. Under health system partnerships, the company shares capital investment costs and profitability based on ownership interests. This model allows health systems to offer advanced treatments like Gamma Knife radiosurgery and proton therapy without bearing the full financial burden.
The earnings call comes at a time when the company is navigating risks such as changes in CMS reimbursement rates, variability in financial results between quarters, and the challenges of expanding into new markets. However, the company's focus on high-demand cancer treatments positions it for potential growth as the need for advanced radiation therapy continues to rise. Investors will be keen to hear about any updates on new partnerships, equipment installations, and patient volume trends during the call.
For more information about American Shared Hospital Services, visit www.ashs.com. The company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2025, provide additional details on risk factors that could affect future results.
